Elhízás: vizsgálatok itt: Görögország

In Görögország 36 Also abroad 1939

36 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.

No phaseTaking people
Exercise Training and Vitamin D Metabolism
Where
Trikala
Életkor
35 év to 50 év
People
30
Run by
University of Thessaly
See details and how to joinNCT07300332
3. fázisTaking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Athens, Heraklion, Thessaloniki
Életkor
18 év to 70 év
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
3. fázisTaking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Athens, Heraklion, Thessaloniki
Életkor
18 év to 70 év
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
3. fázisTaking people
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities
Where
Athens, Larissa, Maroussi, Paleo Faliro, Thessaloniki
Életkor
18 év and over
People
932 worldwide
Run by
Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526172-23-00 · EU 2026-526172-23-00
3. fázisTaking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Alexandroupoli, Athens, Chios, Larissa, Marousi, Marousi, Athens, Nea Ionia, Piraeus, Thessaloniki
Életkor
18 év to 99 év
People
5056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
3. fázisTaking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Where
Alexandroupoli, Athens, Chaïdári, Chios, Larissa, Maroussi, Nea Ionia, Piraeus, Thessaloniki, Voula
Életkor
18 év and over
People
2787 worldwide
Run by
Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00
3. fázisTaking people
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
Where
Athens, Larissa, Maroussi, Paleo Faliro, Thessaloniki
Életkor
18 év and over
People
549 worldwide
Run by
Ascletis Pharma (China) Co. Ltd.
See details and how to join2026-526336-39-00 · EU 2026-526336-39-00
3. fázisNot yet taking people in Görögország
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Athens, Chaïdári, Chania, Chios, Cholargos, Efkarpia, Eleusina, Ioannina, Kifissia, Larissa, Maroussi, Patras, Peristeri, Thessaloniki
Életkor
45 év to 64 év
People
8500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
3. fázisTaking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Athens, Lamia, Maroussi, Paleo Faliro, Peristeri, Thessaloniki
Életkor
18 év and over
People
2500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
3. fázisTaking people
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Where
Athens, Larissa, Marousi, Palaió Fáliro, Pylaia, Thessaloniki
Életkor
18 év and over
People
1560 worldwide
Run by
Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743450
3. fázisTaking people
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Where
Athens, Larissa, Marousi, Palaió Fáliro, Pylaia, Thessaloniki
Életkor
18 év and over
People
3003 worldwide
Run by
Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743463
3. fázisTaking people
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Where
Kalamata, Maroussi, Peristeri, Thessaloniki
Életkor
18 év and over
People
450 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07770841 · EU 2025-524626-18-00
3. fázisTaking people
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Where
Athens, Iraklio (Kritis), Peristeri, Thessaloniki
Életkor
18 év and over
People
285 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07745504 · EU 2025-524249-29-00
3. fázisTaking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Athens, Chaïdári, Chalkida, Chios, Cholargos, Iraklio (Kritis), Kalamata, Larissa, Maroussi, Melissia, Nea Ionia, Peristeri, Thessaloniki, Voula
Életkor
18 év and over
People
5610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
3. fázisTaking people
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Where
Athens, Chaïdári, Maroussi, Thessaloniki
Életkor
18 év and over
People
400 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07509307 · EU 2024-520445-23-00
No phaseNot yet taking people in Görögország
Chrono-Fasting in Overweight and Obese Adolescents
Where
Larissa
Életkor
12 év to 18 év
People
120
Run by
University of Thessaly
See details and how to joinNCT07759414
No phaseTaking people
25(OH)-Vitamin D and Its Association With Structural and Functional Parameters in Hospitalized Patients With Neurological Diseases
Where
Athens, Nea Liosia
Életkor
20 év to 85 év
People
120
Run by
Dionyssiotis, Yannis, M.D.
See details and how to joinNCT06791044
No phaseTaking people
Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.
Where
Athens
Életkor
18 év and over
People
220
Run by
National and Kapodistrian University of Athens
See details and how to joinNCT07653412
3. fázisTaking people
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Where
Athens, Chaïdári, Maroussi, Thessaloniki
Életkor
18 év and over
People
400 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07481630 · EU 2024-520444-42-00
No phaseNot yet taking people in Görögország
Human Pilot Study for the Investigation of the Role of Bilberry and Olive Bioactives on Oxidative Stress Parameters and Inflammatory Markers.
Where
Athens
Életkor
30 év to 50 év
People
60
Run by
National and Kapodistrian University of Athens
See details and how to joinNCT07659028
No phaseTaking people
Long-term Adaptations of Skeletal Muscle After Hybrid Training
Where
Trikala
Életkor
30 év to 50 év
People
30
Run by
University of Thessaly
See details and how to joinNCT07341711
No phaseTaking people
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
Where
Athens
Életkor
18 év and over
People
100
Run by
Attikon Hospital
See details and how to joinNCT07605572
No phaseTaking people
Evaluation of the Stress Response in Anesthesia Use Inhalation Anesthetic (Desflurane) Versus TIVA for Bariatric Surgery
Where
Athens
Életkor
18 év to 65 év
People
70
Run by
G.Gennimatas General Hospital
See details and how to joinNCT07568938
No phaseTaking people
Effects on Remission of Type 2 Diabetes Mellitus Following Gastric Bypass Alone vs Gastric Bypass Combined With Truncal Vagotomy
Where
Athens
Életkor
18 év to 68 év
People
40
Run by
University Research Institute for the Study of Genetic & Malignant Disorders in Childhood
See details and how to joinNCT07278115
No phaseNot yet taking people in Görögország
AI-INFORMED PEER-MENTORING BEHAVIORAL INTERVENTION FOR OBESITY AND CARDIOVASCULAR DISEASE PRIMARY PREVENTION IN YOUTH
Where
Pátrai
Életkor
12 év to 25 év
People
840 worldwide
Run by
Aikaterini Karaivazoglou
See details and how to joinNCT07505459